140 related articles for article (PubMed ID: 22615622)
1. Preparation and in vitro antibacterial evaluation of gatifloxacin mucoadhesive gellan system.
Kesavan K; Nath G; Pandit J
Daru; 2010; 18(4):237-46. PubMed ID: 22615622
[TBL] [Abstract][Full Text] [Related]
2. Sodium alginate based mucoadhesive system for gatifloxacin and its in vitro antibacterial activity.
Kesavan K; Nath G; Pandit JK
Sci Pharm; 2010; 78(4):941-57. PubMed ID: 21179327
[TBL] [Abstract][Full Text] [Related]
3. Effect of hydroxypropyl-β-cyclodextrin on the ocular bioavailability of dexamethasone from a pH-induced mucoadhesive hydrogel.
Kesavan K; Kant S; Singh PN; Pandit JK
Curr Eye Res; 2011 Oct; 36(10):918-29. PubMed ID: 21950697
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Effectiveness in the Treatment of Experimental Bacterial Keratitis with Ion-activated Mucoadhesive Hydrogel.
Kesavan K; Kant S; Pandit JK
Ocul Immunol Inflamm; 2016 Oct; 24(5):489-92. PubMed ID: 26133969
[TBL] [Abstract][Full Text] [Related]
5. Studies on Poloxamer Based Mucoadhesive Insitu Ophthalmic Hydrogel of Moxifloxacin HCL.
Shastri DH; Prajapati ST; Patel LD
Curr Drug Deliv; 2010 Feb; ():. PubMed ID: 20158483
[TBL] [Abstract][Full Text] [Related]
6. Study of an alginate/HPMC-based in situ gelling ophthalmic delivery system for gatifloxacin.
Liu Z; Li J; Nie S; Liu H; Ding P; Pan W
Int J Pharm; 2006 Jun; 315(1-2):12-7. PubMed ID: 16616442
[TBL] [Abstract][Full Text] [Related]
7. Ion-activated in situ gelling systems for sustained ophthalmic delivery of ciprofloxacin hydrochloride.
Balasubramaniam J; Pandit JK
Drug Deliv; 2003; 10(3):185-91. PubMed ID: 12944139
[TBL] [Abstract][Full Text] [Related]
8. Novel in situ gelling ophthalmic drug delivery system based on gellan gum and hydroxyethylcellulose: Innovative rheological characterization, in vitro and in vivo evidence of a sustained precorneal retention time.
Destruel PL; Zeng N; Seguin J; Douat S; Rosa F; Brignole-Baudouin F; Dufaÿ S; Dufaÿ-Wojcicki A; Maury M; Mignet N; Boudy V
Int J Pharm; 2020 Jan; 574():118734. PubMed ID: 31705970
[TBL] [Abstract][Full Text] [Related]
9. Design and Development of Thermoreversible Ophthalmic In Situ Hydrogel of Moxifloxacin HCl.
Shastri DH; Prajapati ST; Patel LD
Curr Drug Deliv; 2010 Jul; 7(3):238-43. PubMed ID: 20497100
[TBL] [Abstract][Full Text] [Related]
10. Optimization of a novel in situ gel for sustained ocular drug delivery using Box-Behnken design: In vitro, ex vivo, in vivo and human studies.
Ranch KM; Maulvi FA; Naik MJ; Koli AR; Parikh RK; Shah DO
Int J Pharm; 2019 Jan; 554():264-275. PubMed ID: 30423418
[TBL] [Abstract][Full Text] [Related]
11. Sustained ocular delivery of brimonidine tartrate using ion activated in situ gelling system.
Geethalakshmi A; Karki R; Jha SK; Venkatesh DP; Nikunj B
Curr Drug Deliv; 2012 Mar; 9(2):197-204. PubMed ID: 22283647
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo ocular safety and eye surface permanence determination by direct and Magnetic Resonance Imaging of ion-sensitive hydrogels based on gellan gum and kappa-carrageenan.
Fernández-Ferreiro A; González Barcia M; Gil-Martínez M; Vieites-Prado A; Lema I; Argibay B; Blanco Méndez J; Lamas MJ; Otero-Espinar FJ
Eur J Pharm Biopharm; 2015 Aug; 94():342-51. PubMed ID: 26079831
[TBL] [Abstract][Full Text] [Related]
13. Ocular Mucoadhesive and Biodegradable Sponge-Like Inserts for the Sustained and Controlled Delivery of Voriconazole; Preparation, D-optimal Factorial Optimization and in-vivo Evaluation.
Said M; Elsayed I; Aboelwafa AA; Elshafeey AH; Hassan M
J Pharm Sci; 2024 Apr; 113(4):961-973. PubMed ID: 37949171
[TBL] [Abstract][Full Text] [Related]
14. Preparation and evaluation of nanoparticles loaded ophthalmic in situ gel.
Kesarla R; Tank T; Vora PA; Shah T; Parmar S; Omri A
Drug Deliv; 2016 Sep; 23(7):2363-2370. PubMed ID: 25579467
[TBL] [Abstract][Full Text] [Related]
15. Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system.
Srividya B; Cardoza RM; Amin PD
J Control Release; 2001 Jun; 73(2-3):205-11. PubMed ID: 11516498
[TBL] [Abstract][Full Text] [Related]
16. Sustained ophthalmic delivery of ofloxacin from an ion-activated in situ gelling system.
Abraham S; Furtado S; Bharath S; Basavaraj BV; Deveswaran R; Madhavan V
Pak J Pharm Sci; 2009 Apr; 22(2):175-9. PubMed ID: 19339228
[TBL] [Abstract][Full Text] [Related]
17. Formulation and evaluation of an in situ gel-forming ophthalmic formulation of moxifloxacin hydrochloride.
Mandal S; Thimmasetty MK; Prabhushankar G; Geetha M
Int J Pharm Investig; 2012 Apr; 2(2):78-82. PubMed ID: 23119236
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo evaluation of the Gelrite gellan gum-based ocular delivery system for indomethacin.
Balasubramaniam J; Kant S; Pandit JK
Acta Pharm; 2003 Dec; 53(4):251-61. PubMed ID: 14769232
[TBL] [Abstract][Full Text] [Related]
19. Use of factorial design in formulation and evaluation of ophthalmic gels of gatifloxacin: Comparison of different mucoadhesive polymers.
Gonjari ID; Karmarkar AB; Khade TS; Hosmani AH; Navale RB
Drug Discov Ther; 2010 Dec; 4(6):423-34. PubMed ID: 22491308
[TBL] [Abstract][Full Text] [Related]
20. Development and characterization of in-situ gel for ophthalmic formulation containing ciprofloxacin hydrochloride.
Makwana SB; Patel VA; Parmar SJ
Results Pharma Sci; 2016; 6():1-6. PubMed ID: 26949596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
